A polygenic risk score (PRS) using germline DNA extracted from saliva identified a higher proportion of individuals with clinically significant prostate cancer warranting treatment compared with prostate-specific antigen (PSA) testing or MRI,…
Prostate Cancer Testing Via Polygenic Risk Score Outperforms Standard Approaches
